Adverum Biotechnologies, Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Adverum Biotechnologies, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Adverum Biotechnologies, Inc. Return On Equity for the quarter ending September 30, 2024 was -65.1 %, a 26% increase year-over-year.
  • Adverum Biotechnologies, Inc. annual Return On Equity for 2023 was -98.7 %, a 46.3% decline from 2022.
  • Adverum Biotechnologies, Inc. annual Return On Equity for 2022 was -67.4 %, a 68.6% decline from 2021.
  • Adverum Biotechnologies, Inc. annual Return On Equity for 2021 was -40 %, a 26.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -98.7 -31.2 -46.3% Jan 1, 2023 Dec 31, 2023
2022 -67.4 -27.4 -68.6% Jan 1, 2022 Dec 31, 2022
2021 -40 -8.34 -26.4% Jan 1, 2021 Dec 31, 2021
2020 -31.6 +4.95 +13.5% Jan 1, 2020 Dec 31, 2020
2019 -36.6 -4.17 -12.9% Jan 1, 2019 Dec 31, 2019
2018 -32.4 -2.81 -9.49% Jan 1, 2018 Dec 31, 2018
2017 -29.6 +18.7 +38.8% Jan 1, 2017 Dec 31, 2017
2016 -48.4 -30.5 -171% Jan 1, 2016 Dec 31, 2016
2015 -17.8 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.